417 related articles for article (PubMed ID: 11315926)
1. Biologic activity and plasma clearance of prolactin-IgG complex in patients with systemic lupus erythematosus.
Leaños-Miranda A; Chávez-Rueda KA; Blanco-Favela F
Arthritis Rheum; 2001 Apr; 44(4):866-75. PubMed ID: 11315926
[TBL] [Abstract][Full Text] [Related]
2. Elevated bioactive prolactin levels in systemic lupus erythematosus--association with disease activity.
Pacilio M; Migliaresi S; Meli R; Ambrosone L; Bigliardo B; Di Carlo R
J Rheumatol; 2001 Oct; 28(10):2216-21. PubMed ID: 11669159
[TBL] [Abstract][Full Text] [Related]
3. Elevated serum bioactive prolactin concentrations in patients with systemic lupus erythematosus are associated with disease activity as disclosed by homologous receptor bioassays.
Cárdenas-Mondragón G; Ulloa-Aguirre A; Isordia-Salas I; Goffin V; Leaños-Miranda A
J Rheumatol; 2007 Jul; 34(7):1514-21. PubMed ID: 17516622
[TBL] [Abstract][Full Text] [Related]
4. Persistence of macroprolactinemia due to antiprolactin autoantibody before, during, and after pregnancy in a woman with systemic lupus erythematosus.
Leaños-Miranda A; Pascoe-Lira D; Chávez-Rueda KA; Blanco-Favela F
J Clin Endocrinol Metab; 2001 Jun; 86(6):2619-24. PubMed ID: 11397862
[TBL] [Abstract][Full Text] [Related]
5. Serum free prolactin concentrations in patients with systemic lupus erythematosus are associated with lupus activity.
Leaños-Miranda A; Cárdenas-Mondragón G
Rheumatology (Oxford); 2006 Jan; 45(1):97-101. PubMed ID: 16249247
[TBL] [Abstract][Full Text] [Related]
6. Antiprolactin autoantibodies in systemic lupus erythematosus: frequency and correlation with prolactinemia and disease activity.
Leaños-Miranda A; Pascoe-Lira D; Chávez-Rueda KA; Blanco-Favela F
J Rheumatol; 2001 Jul; 28(7):1546-53. PubMed ID: 11469460
[TBL] [Abstract][Full Text] [Related]
7. Anti-prolactin autoantibodies in pregnant women with systemic lupus erythematosus: maternal and fetal outcome.
Leaños-Miranda A; Cárdenas-Mondragón G; Ulloa-Aguirre A; Isordia-Salas I; Parra A; Ramírez-Peredo J
Lupus; 2007; 16(5):342-9. PubMed ID: 17576736
[TBL] [Abstract][Full Text] [Related]
8. Characterization of big, big prolactin in patients with hyperprolactinaemia.
Leite V; Cosby H; Sobrinho LG; Fresnoza MA; Santos MA; Friesen HG
Clin Endocrinol (Oxf); 1992 Oct; 37(4):365-72. PubMed ID: 1483294
[TBL] [Abstract][Full Text] [Related]
9. Elevated serum prolactin or elevated prolactin/cortisol ratio are associated with autoimmune processes in systemic lupus erythematosus and other connective tissue diseases.
Neidhart M
J Rheumatol; 1996 Mar; 23(3):476-81. PubMed ID: 8832986
[TBL] [Abstract][Full Text] [Related]
10. [Antibodies against prolactin in patients with systemic lupus erythematosus and hyperprolactinemia].
Leaños Miranda L; Bustos López HH; Fraga Mouret A; Blanco Favela F; Dalila Pascoe Lira ME; Dalila Pascoe Lira C
Ginecol Obstet Mex; 1998 May; 66():179-86. PubMed ID: 9646575
[TBL] [Abstract][Full Text] [Related]
11. Anti-prolactin (PRL) autoantibodies cause asymptomatic hyperprolactinemia: bioassay and clearance studies of PRL-immunoglobulin G complex.
Hattori N; Inagaki C
J Clin Endocrinol Metab; 1997 Sep; 82(9):3107-10. PubMed ID: 9284753
[TBL] [Abstract][Full Text] [Related]
12. No correlation between prolactin levels and clinical activity in patients with systemic lupus erythematosus.
Buskila D; Lorber M; Neumann L; Flusser D; Shoenfeld Y
J Rheumatol; 1996 Apr; 23(4):629-32. PubMed ID: 8730116
[TBL] [Abstract][Full Text] [Related]
13. Hyperprolactinemia in males with systemic lupus erythematosus.
Mok CC; Lau CS; Lee KW; Wong RW
J Rheumatol; 1998 Dec; 25(12):2357-63. PubMed ID: 9858430
[TBL] [Abstract][Full Text] [Related]
14. Analysis of anti-prolactin autoantibodies in systemic lupus erythematosus.
Blanco-Favela F; Chavez-Rueda K; Leaños-Miranda A
Lupus; 2001; 10(10):757-61. PubMed ID: 11721703
[TBL] [Abstract][Full Text] [Related]
15. Anti-prolactin autoantibodies in paediatric systemic lupus erythematosus patients.
Blanco-Favela F; Quintal MaG ; Chavez-Rueda AK; Leaños-Miranda A; Berron-Peres R; Baca-Ruiz V; Lavalle-Montalvo C
Lupus; 2001; 10(11):803-8. PubMed ID: 11789490
[TBL] [Abstract][Full Text] [Related]
16. Identification of macroprolactin in a patient with asymptomatic hyperprolactinemia as a stable PRL-IgG complex.
Bonhoff A; Vuille JC; Gomez F; Gellersen B
Exp Clin Endocrinol Diabetes; 1995; 103(4):252-5. PubMed ID: 7584531
[TBL] [Abstract][Full Text] [Related]
17. Molecular heterogeneity of prolactin in the plasma of patients with systemic lupus erythematosus.
Cruz J; Aviña-Zubieta A; Martínez de la Escalera G; Clapp C; Lavalle C
Arthritis Rheum; 2001 Jun; 44(6):1331-5. PubMed ID: 11407692
[TBL] [Abstract][Full Text] [Related]
18. Altered diurnal rhythm of prolactin in systemic sclerosis.
Hilty C; Brühlmann P; Sprott H; Gay RE; Michel BA; Gay S; Neidhart M
J Rheumatol; 2000 Sep; 27(9):2160-5. PubMed ID: 10990228
[TBL] [Abstract][Full Text] [Related]
19. Some forms of big big prolactin behave as a complex of monomeric prolactin with an immunoglobulin G in patients with macroprolactinemia or prolactinoma.
Cavaco B; Leite V; Santos MA; Arranhado E; Sobrinho LG
J Clin Endocrinol Metab; 1995 Aug; 80(8):2342-6. PubMed ID: 7629227
[TBL] [Abstract][Full Text] [Related]
20. Anti-prolactin (PRL) autoantibody-binding sites (epitopes) on PRL molecule in macroprolactinemia.
Hattori N; Nakayama Y; Kitagawa K; Ishihara T; Saiki Y; Inagaki C
J Endocrinol; 2006 Aug; 190(2):287-93. PubMed ID: 16899562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
